Ge Long Hui A P P·2026-01-13 08:13Core Viewpoint - The company Xinhecheng is positioned as a global leader in the fine chemical industry, leveraging high-barrier core intermediates and focusing on domestic substitution to drive growth [1] Group 1: Business Strategy - The company has successfully overcome challenges in the domestic production of Vitamin A and E, and is now extending its industrial chain through high-barrier core intermediates, customer collaboration, and domestic substitution [1] - The company has diversified into multiple sectors including nutrition products, flavor and fragrance, new materials, active pharmaceutical ingredients, and intermediates, as well as bio-fermentation [1] Group 2: Market Conditions - Current methionine prices are declining, but the cost curve remains steep with strong bottom support; the company is positioned at the leftmost side of this curve, ensuring solid bottom-line profits [1] - Overseas production capacity is gradually exiting due to cost and environmental pressures, with the EU carbon tariff in 2026 potentially accelerating this trend, leading to expected price elasticity for methionine [1] Group 3: Future Prospects - In 2025, the company plans to implement a 70,000-ton solid methionine technical upgrade and an 180,000-ton liquid methionine project, which may lead to simultaneous volume and profit growth in 2026 [1] - The flavor and fragrance segment continues to expand, showing steady growth, while new materials demonstrate industrial and technological synergy, with additional growth potential from adiponitrile [1] - Given the company's status as a global leader in fine chemicals, its significant scale cost advantages, and the cyclical bottom with elasticity and new material growth potential, a "buy" rating is maintained [1]